Table 3 PVR cut-off for different targets
From: Myocardial contractility in the stress echo lab: from pathophysiological toy to clinical tool
Author, year | Stress | PVR cutoff (mmHg/mL/m2) | Clinical target |
|---|---|---|---|
Bombardini et al., JASE 2003 [6] | EX | <4.7 | Patients vs normal |
Agricola et al., Am J Cardiol 2005 [18] | EX | < 2.1 | Pulmonary hypertension in MR |
Bombardini et al., Int J Cardiol 2008 [15] | EX | < 2.2 | Prognosis in negative stress |
Agricola et al., Int J Cardiol 2008 [23] | EX | < 0.4 | Prognosis in MR in DCM/DC |
Jellis et al., Circ Cl 2010 [28] | EX | ≤ 12 | Subclinical heart disease in diabetic type 2 |
Grosu et al., Eur Heart J 2005 [7] | DOB | < 0.2 | Prognosis in DCM/DC |
Otasevic et al., Heart 2006 [20] | DOB | < 0.4 | Prognosis in DCM |
Ciampi et al., JASE 2010 [22] | DOB | > 1.4 | Exercise tolerance in CHF |
Ciampi et al., Am Heart J 2010 [24] | DOB | > 0.7 | CRT responders |
Otasevic et al., Eur J Heart Fail 2005 [21] | DIP | < 0.6 | Prognosis in DCM |
Bombardini et al., JASE 2011 [17] | DIP | ≤ 0 | Subclinical heart disease in heart donors |
Bombardini et al., Eur J Heart Fail 2005 [8] | PM | < 2.5 | Patients vs normal |